Literature DB >> 23879830

Metformin does not enhance insulin-stimulated vasodilation in skeletal muscle resistance arteries of the OLETF rat.

Jacqueline M Crissey1, Jaume Padilla, Nathan T Jenkins, Jeffrey S Martin, Randy Scott Rector, John P Thyfault, Maurice Harold Laughlin.   

Abstract

OBJECTIVE: To test the hypothesis that chronic metformin treatment enhances insulin-induced vasodilation in skeletal muscle resistance arteries and arterioles.
METHODS: We assessed the effect of metformin treatment (from 20 to 32 weeks of age) of obese Otsuka Long Evans Tokushima Fatty (OLETF) rats and lean LETO rats (300 mg/kg) on insulin-stimulated vasodilation in isolated skeletal muscle feed arteries and arterioles.
RESULTS: Metformin treatment significantly lowered food intake, body weight, percent body fat, and HbA1c in OLETF rats. Metformin resulted in a ~30% reduction in insulin-induced vasodilation of soleus feed arteries (SFA) from OLETF rats. Inhibition of endothelin-1 (ET-1) signaling produced 20% dilation and eliminated the difference between metformin-treated and untreated OLETF rats in insulin-induced dilation of SFA. In contrast to the SFA, metformin did not alter insulin-stimulated vasodilation in gastrocnemius feed arteries (GFA), or second-order arterioles in the red (G2A-R) or white (G2A-W) portions of the gastrocnemius muscle of OLETF rats. Metformin had no effects on vasomotor responses of arteries from LETO.
CONCLUSIONS: Although metformin exerts favorable effects on body composition and HbA1c, it does not enhance the vasodilatory responses to insulin in the skeletal muscle feed arteries or arterioles of the obese OLETF rat.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  insulin resistance; metformin; microvascular disease; type 2 diabetes

Mesh:

Substances:

Year:  2013        PMID: 23879830      PMCID: PMC4423537          DOI: 10.1111/micc.12078

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  61 in total

1.  Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.

Authors:  M S Wu; P Johnston; W H Sheu; C B Hollenbeck; C Y Jeng; I D Goldfine; Y D Chen; G M Reaven
Journal:  Diabetes Care       Date:  1990-01       Impact factor: 19.112

2.  Metformin, but not exercise training, increases insulin responsiveness in skeletal muscle of Sprague-Dawley rats.

Authors:  S E Borst; H G Snellen
Journal:  Life Sci       Date:  2001-08-17       Impact factor: 5.037

3.  Aging induces muscle-specific impairment of endothelium-dependent dilation in skeletal muscle feed arteries.

Authors:  Christopher R Woodman; Elmer M Price; M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2002-11

4.  Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.

Authors:  Kirsti Hällsten; Kirsi A Virtanen; Fredrik Lönnqvist; Hannu Sipilä; Airi Oksanen; Tapio Viljanen; Tapani Rönnemaa; Jorma Viikari; Juhani Knuuti; Pirjo Nuutila
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

5.  Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats.

Authors:  Michelle G Wallis; Catherine M Wheatley; Stephen Rattigan; Eugene J Barrett; Andrew D H Clark; Michael G Clark
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

Review 6.  Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium.

Authors:  Michelle A Vincent; Monica Montagnani; Michael J Quon
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

Review 7.  Metformin: an update.

Authors:  Dmitri Kirpichnikov; Samy I McFarlane; James R Sowers
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

8.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats.

Authors:  Kaoruko Tada Iida; Yasushi Kawakami; Masatsune Suzuki; Hitoshi Shimano; Hideo Toyoshima; Hirohito Sone; Kazunori Shimada; Yoshitaka Iwama; Yoshiro Watanabe; Hiroshi Mokuno; Katsuo Kamata; Nobuhiro Yamada
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-02-04       Impact factor: 4.310

10.  Differential adenosine sensitivity of diaphragm and skeletal muscle arterioles.

Authors:  Aaron Aaker; M H Laughlin
Journal:  J Appl Physiol (1985)       Date:  2002-09
View more
  6 in total

1.  A chronic physical activity treatment in obese rats normalizes the contributions of ET-1 and NO to insulin-mediated posterior cerebral artery vasodilation.

Authors:  T Dylan Olver; Matthew W McDonald; Diana Klakotskaia; Rachel A Richardson; Jeffrey L Jasperse; C W James Melling; Todd R Schachtman; Hsiao T Yang; Craig A Emter; M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2017-02-09

Review 2.  Exercise and Vascular Insulin Sensitivity in the Skeletal Muscle and Brain.

Authors:  T Dylan Olver; M Harold Laughlin; Jaume Padilla
Journal:  Exerc Sport Sci Rev       Date:  2019-04       Impact factor: 6.230

3.  Microvascular insulin resistance in skeletal muscle and brain occurs early in the development of juvenile obesity in pigs.

Authors:  T Dylan Olver; Zachary I Grunewald; Thomas J Jurrissen; Rebecca E K MacPherson; Paul J LeBlanc; Teagan R Schnurbusch; Alana M Czajkowski; M Harold Laughlin; R Scott Rector; Shawn B Bender; Eric M Walters; Craig A Emter; Jaume Padilla
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-12-04       Impact factor: 3.619

4.  Persistent insulin signaling coupled with restricted PI3K activation causes insulin-induced vasoconstriction.

Authors:  T Dylan Olver; Zachary I Grunewald; Thaysa Ghiarone; Robert M Restaino; Allan R K Sales; Lauren K Park; Pamela K Thorne; Rama Rao Ganga; Craig A Emter; Peter W R Lemon; J Kevin Shoemaker; Camila Manrique-Acevedo; Luis A Martinez-Lemus; Jaume Padilla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-10-11       Impact factor: 4.733

5.  Transcriptomic effects of metformin in skeletal muscle arteries of obese insulin-resistant rats.

Authors:  Jaume Padilla; Pamela K Thorne; Jeffrey S Martin; R Scott Rector; Sadia Akter; J Wade Davis; M Harold Laughlin; Nathan T Jenkins
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-23

Review 6.  Endurance, interval sprint, and resistance exercise training: impact on microvascular dysfunction in type 2 diabetes.

Authors:  T Dylan Olver; M Harold Laughlin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-25       Impact factor: 4.733

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.